Doximity Reports Q2 Fiscal 2027 Revenue of $175 Million Driven by AI Adoption
Doximity (DOCS) reported second-quarter fiscal 2027 revenue of $175 million, highlighting significant growth driven by the integration of artificial intelligence into its clinical workflow tools. A key driver is the company's new commercial AI search capability, which has already been adopted by 16 of the top 20 pharmaceutical companies, positioning Doximity to capture a portion of the $14 billion annual digital pharma advertising market. The platform saw a 34% year-over-year increase in quarterly active workflow prescribers, signaling deep engagement within the medical community. Despite the high computational demands of AI, management noted that optimized infrastructure and prebought compute capacity have allowed for cost leverage, keeping profit margins stable even as usage scales.
Tickers: $DOCS
Topics: artificial intelligence earnings report healthcare technology pharmaceutical advertising